Danish study to track early melanoma after surgery
Part of Cancer, Skin clinical trials.
This study tests a new way to monitor people after surgery for early-stage melanoma. If you qualify, it may help your doctors watch for changes sooner or more accurately during follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read and understand Danish
- You can give written informed consent
- You had surgery for melanoma stage IA to IIA within the last 3 months
- Your melanoma is not advanced (not stages IIB, IIC, III, or IV)
- You do not have a condition that greatly increases the chance of new melanoma (like dysplastic nevus syndrome or strong family history)
- You do not have medical or thinking problems that make skin self-checks impossible
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares less invasive procedures with the current standard treatment for early-stage melanoma in adults 75 and older. The goal is to find out if these less invasive options work just as well and help patients recover better.
This trial tests two methods of checking removed melanoma tissue to see which gives clearer results. It may help improve how doctors determine if all cancer was removed.
This study looks at diagnostic and prognostic factors in people who have suspicious pigmented skin lesions or melanoma that doctors are evaluating with surgery or tissue sampling. It may help improve how clinicians decide what the lesion is and what to expect over time.
This trial studies whether adding or adjusting imaging scans during follow-up after melanoma surgery can help detect recurrence earlier. It compares different follow-up imaging schedules for people at higher risk after surgery.
This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.
This trial tests a personalized aftercare report for people with low-risk skin cancer. It aims to see if this report can improve follow-up care.
Hear when a new Cutaneous Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.